Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study.

Rheumatology (Oxford, England)

Volumn 49, Issue 4, 2010, Pages 716-722

  Mackie, Sarah L ^a   Hensor, Elizabeth M A ^b   Haugeberg, Glenn ^b   Bhakta, Bipin ^b   Pease, Colin T ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; HLA ANTIGEN; PREDNISOLONE; STEROID;

AGED; ARTICLE; FEMALE; FOLLOW UP; GENETICS; GIANT CELL ARTERITIS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RHEUMATIC POLYMYALGIA;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; FEMALE; FOLLOW-UP STUDIES; GIANT CELL ARTERITIS; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA; PREDICTIVE VALUE OF TESTS; PREDNISOLONE; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; STEROIDS;

EID: 79051471670     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep395     Document Type: Article

References (0)